STXS logo

STXS
Stereotaxis Inc

2,050
Mkt Cap
$185.21M
Volume
82,421.00
52W High
$3.59
52W Low
$1.74
PE Ratio
-7.63
STXS Fundamentals
Price
$1.92
Prev Close
$1.92
Open
$1.93
50D MA
$1.95
Beta
1.17
Avg. Volume
414,078.54
EPS (Annual)
-$0.2519
P/B
13.58
Rev/Employee
$247,152.67
$206.46
Loading...
Loading...
News
all
press releases
Integra LifeSciences (IART) Beats Q1 Earnings and Revenue Estimates
Integra (IART) delivered earnings and revenue surprises of +32.78% and +2.74%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1d ago
News Placeholder
More News
News Placeholder
Stereotaxis Stock Up on First U.S. MAGiC Procedures Post Approval
STXS stock gains after first U.S. MAGiC procedures, marking a key milestone in robotic cardiac care and boosting its growth outlook.
Zacks·13d ago
News Placeholder
STXS to Acquire Robocath to Lead in Endovascular Robotics Market
Stereotaxis expands in robotic surgery with Robocath acquisition, aiming to build a comprehensive endovascular platform and unlock growth opportunities.
Zacks·19d ago
News Placeholder
STXS Gains on FDA Nod for Synchrony System, Expands Digital Surgery
STXS jumps on FDA clearance of Synchrony system, a 4K platform integrating cath lab tech with cloud connectivity to boost workflow, precision and digital surgery.
Zacks·29d ago
News Placeholder
Intuitive Surgical Under Pressure in China: Can It Defend Its Position?
ISRG faces rising pricing pressure in China as local rivals gain ground, but its ecosystem, local manufacturing and disciplined pricing aim to defend its position.
Zacks·1mo ago
News Placeholder
Stereotaxis Inc. (STXS) Reports Q4 Loss, Lags Revenue Estimates
Stereotaxis (STXS) delivered earnings and revenue surprises of +5.21% and -5.55%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Beats Revenue Estimates
Sight Sciences (SGHT) delivered earnings and revenue surprises of +44.83% and +0.34%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Can Digital Subscriptions Become ISRG's New Revenue Stream in 2026?
Intuitive Surgical's My Intuitive+ may turn paid in 2026, adding a software-driven revenue layer as renewals begin and digital engagement scales.
Zacks·2mo ago
News Placeholder
OrthoPediatrics (KIDS) Reports Q4 Loss, Tops Revenue Estimates
OrthoPediatrics (KIDS) delivered earnings and revenue surprises of +29.73% and +4.05%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
TransMedics (TMDX) Beats Q4 Earnings and Revenue Estimates
TransMedics (TMDX) delivered earnings and revenue surprises of +40.02% and +3.11%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
<
1
2
...
>

Latest STXS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.